Neuroleptic malignant syndrome associated with severe thrombocytopenia

Journal of Internal Medicine

Volumn 241, Issue 3, 1997, Pages 249-251

  Ray, J G ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE   (Canada)

Author keywords

neuroleptic malignant syndrome; neuroleptics; thrombocytopenia

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; PERPHENAZINE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0030990593     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.71898000.x     Document Type: Article

References (13)

1. Delay J, Deniker P. Drug-induced extrapyramidal syndromes. In: Vinkin PJ, Bruyn GW, eds. Handbook of Clinical Neurology: Diseases of the Basal Ganglia, Vol 6. Amsterdam: North Holland Publishing, 1968; 248-66.
2. Guze BH, Baxter LR. Neuroleptic malignant syndrome. N Engl J Med 1985; 313: 163-6.
3. Chaimowitz GA, Gomes U, Maze SS. Neuroleptic malignant syndrome. Can Med Assoc J 1988; 138: 51-2.
4. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am 1993; 77: 185-202.
5. Heiman-Patterson TD. Neuroleptic malignant syndrome and hyperthermia. Med Clin North Am 1993; 77: 477-90.
6. Lenler-Peterson R, Hansen BD, Hasselstrom L. A rapidly progressing lethal case of neuroleptic malignant syndrome. Intensive Care Med 1990; 16: 267-8.
7. Lowy A, Wilson A, Sachdev P, Lindeman R. Disseminated intravascular coagulopathy and thrombocytopenia associated with clozapine-induced neuroleptic malignant syndrome. Aust NZ J Med 1995; 25: 368.
8. Holt RJ. Neuroleptic drug-induced changes in platelet levels. J Clin Psychopharm 1984; 4: 130-3.
9. Balon R, Berchou R. Hematologic side effects of psychotropic drugs. Psychosomatics 1986; 27: 119-27.
10. Storrie MC, Scher M, McGuire J, Bokan J. Thrombocytopenia in the absence of leucopenia associated with the use of neuroleptics. J Clin Psychiatry 1978; 39: 779-81.
11. Yao JK, Yasaei P, van Kammen DP. Increased turnover of platelet phosphatidylinositol in schizophrenia. Prostaglandins Leukotrienes and Essential Fatty Acids 1992; 46: 39-46.
12. Kaiya H. Second messenger imbalance hypothesis of schizophrenia. Prostaglandins Leukotrienes and Essential Fatty Acids 1992; 46: 33-8.
13. George JN, Shattil SJ. The clinical importance of acquired abnormalities of platelet function. N Engl J Med 1991; 324: 27-39.